Blood-Brain Barrier (BBB) Market by Type, Application and Manufacturers Industry Revenue Analysis and Forecasts by 2028

The Global Blood-Brain Barrier (BBB) Market size is expected to reach USD 7.40 Billion in 2028 at a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Major factors driving market revenue growth include major prevalence of neurological disorders such as Parkinson’s Disease, Alzheimer’s Disease, Hunter’s Syndrome, and brain tumors. Other factors include rising healthcare expenses and increasing investment in pharmaceutical research and development. Blood-brain barrier plays a vital role in protecting the brain from toxic compounds and many blood-borne disorders. It helps to prevent the circulation of compounds from the circulatory systems to Cerebrospinal Fluid (CSF) or brain through a particular exchange of components controlled by BBB or blood CSF barrier. This function also significantly impedes delivery of drugs to the brain. In case of central nervous system disorders, it is required to deliver drugs across this barrier and provide the appropriate therapeutic effect to the targeted location.

Ongoing technological developments in magnetic resonance imaging technology that helps to identify blood-brain barrier and introduction of advanced nanotechnology and ultrasound applications is expected to drive market revenue growth going ahead.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/633

Some Key Findings From the Report:

In January 2021, Nanoform Finland signed an agreement with Herantis Pharma. This agreement will help both companies to improve blood-brain-barrier penetration in nasal drug delivery routes for Parkinson’s therapies using nanoparticle technology.
Parkinson’s disease segment accounted for major revenue share in global market in 2020 and is expected to register a 25.1% CAGR throughout the forecast period. This is attributed to major prevalence of Parkinson’s Disease among an expanding global patient pool.
Asia Pacific is expected to register the fastest revenue CAGR throughout the forecast period, which can be attributed to rapid advancements in pharmaceutical and healthcare infrastructure, increasing aging population, major prevalence of neurological disorders, increasing number of hospitals and long-term care facilities in countries across the globe.

Top competitors of the Blood-Brain Barrier (BBB) Market profiled in the report include:

Allon Therapeutics, Inc., Angiochem Inc., Armagen Technologies, Inc., Bristol-Myers Squibb, BiOasis Technologies, Inc., Sanofi Genzyme, CarThera, Cephalon Inc., Nanomerics, and F. Hoffman La-Roche AG.

Request a discount on the report @ https://www.emergenresearch.com/request-discount/633

For the purpose of this report, Emergen Research has segmented the global blood-brain barrier (BBB) market based on application, technology, end-use, and by region:

Application Outlook (Revenue, USD Billion; 2018–2028)

Alzheimer’s Disease
Epilepsy
Parkinson’s Disease
Multiple Sclerosis
Hunter’s Syndrome
Brain Cancer

Technology Outlook (Revenue, USD Billion; 2018–2028)

Bispecific Antibody RMT Approach
Trojan Horse Approach
Increasing Permeability
Passive Diffusion
Others

End-Use Outlook (Revenue, USD Billion; 2018–2028)

Hospitals
Surgical centers
Research Institutes
Others

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/blood-brain-barrier-market

Regional Outlook (Revenue: USD Billion; 2018–2028)

North America
1. U.S.
2. Canada
3. Mexico
Europe
1. Germany
2. France
3. U.K.
4. BENELUX
5. Italy
6. Spain
7. Switzerland
8. Russia
9. Rest of Europe
Asia Pacific
1. China
2. Japan
3. South Korea
4. India
5. Rest of APAC
Latin America
1. Brazil
2. Rest of LATAM
Middle East & Africa
1. Saudi Arabia
2. UAE
3. South Africa
4. Turkey
5. Rest of MEA

Key Objectives of the Report:

Analysis and estimation of the Blood-Brain Barrier (BBB) market size and share for the projected period of 2020-2028
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Blood-Brain Barrier (BBB) market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

About Emergen Research

Emergen Research is a Marketresearch and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer Marketintelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkedIn | Twitter | Blogs

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Explore More Emergen Research Reports @

Health Data Archiving Market

AI-based Clinical Trials Solution Provider Market